Poems Syndrome
📧 Sign up to get email alerts when something new happens for Poems Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS
A clinical trial evaluating the pathologic role of the gene IGLV1-44 in AL amyloidosis and POEMS syndrome is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders
A Mayo Clinic-sponsored clinical trial is evaluating the gut microbiome in patients with POEMS syndrome and other plasma cell disorders; rec…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Registry for Adults With Plasma Cell Disorders (PCD's)
Clinical trial registry update for adults with plasma cell disorders indicating active recruitment. The study is sponsored by UNC Lineberger…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: BCMA/CD3 BsAb Therapy for POEMS Syndrome [Phase 2]
Phase 2 clinical trial testing a BCMA/CD3 bispecific antibody therapy for POEMS syndrome; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
A clinical trial update for the PolyImPAct study investigating polyneuropathy, impairments, and physical activity, currently recruiting and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome [EARLY_Phase 1]
Clinical trial update on an early-phase 1 study of ixazomib citrate, lenalidomide, and dexamethasone for POEMS syndrome (plasmacytoma) that …
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System [EARLY_Phase 1]
An early-phase clinical trial is investigating CT103A cell therapy for relapsed/refractory antibody-associated inflammatory diseases of the …
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome [Phase 1]
This update announces a Phase 1 clinical trial of KQ-2003 CAR-T cell therapy for relapsed or refractory POEMS syndrome, which is not yet rec…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Treatment of POEMS Syndrome With Daratumumab [Phase 2]
Phase 2 clinical trial evaluating daratumumab for POEMS syndrome has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: POEMS Syndrome Treatment With Lenalidomide [Phase 2]
Phase 2 clinical trial evaluating lenalidomide for POEMS syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome [Phase 2]
A Phase 2 trial evaluating lenalidomide plus dexamethasone in newly diagnosed POEMS syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial [Phase 2]
Phase 2 trial results show the efficacy and safety of lenalidomide in patients with recurrent or refractory POEMS syndrome; the study status…
-
CLINICAL_TRIALS trial_result · 2010-09-02Clinical Trial Update: The Treatment of Lenalidomide in Patients With POEMS Syndrome [Phase 2]
This entry concerns a Phase 2 clinical trial evaluating lenalidomide for POEMS syndrome. The status of the trial is unknown.